Exchange of sera and standardization of the methodology employed, whether it is radioligand, western blot or ELISA is urgently warranted to address definitely whether anti-LC1 and anti-SLA autoantibodies are serological markers of chronic hepatitis C. This evidence concerns the gene DNAL1 and chronic hepatitis C virus infection.